Cardiovascular Systems, Inc., a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced that management plans to present and host investor meetings at the Raymond James Human Health Innovations Conference on June 23rd.
ST. PAUL, Minn.--(BUSINESS WIRE)-- Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that management plans to present and host investor meetings at the Raymond James Human Health Innovations Conference on June 23rd. A webcast of the presentation will be made available on CSI’s website.
Raymond James Human Health Innovations Conference
Wednesday, June 23, 2021
10:40 a.m. ET
About Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company’s orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives. For additional information, please visit www.csi360.com and connect on Twitter @csi360.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210602005172/en/
Cardiovascular Systems, Inc.
Jack Nielsen
Vice President, Investor Relations
& Corporate Communications
(651) 202-4919
j.nielsen@csi360.com
Source: Cardiovascular Systems, Inc.
View this news release online at:
http://www.businesswire.com/news/home/20210602005172/en
